You can buy or sell IBB and other stocks, options, ETFs, and crypto commission-free!
IBB tracks the performance of a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.
52 Week High
52 Week Low
Seeking AlphaMar 19
Biotech Hype Is Worth Every Penny, But IBB Is Not The Best Way To Play It
IBB is not a bad way to gain some exposure to biotech stocks, but is not the best way to do so. Healthcare industry is poised to grow for many years to come, and biotech stocks are considered hot by many investors and analysts. Executive summary Technological advancements have taken the world by storm, and these technological developments are changing some industries for good. For example, the retail shopping industry has been disrupted by the rise of e-commerce, and the cable-TV industry has been trumpe...
Biotech stocks are tracking for their best quarter ever — here's how to play it
Biotech stocks took a tumble Monday with the XBI S&P biotech ETF and IBB Nasdaq biotech ETF each falling by more than 1 percent. Even so, the two ETFs remain sharply higher for the year. The equal-weighted XBI ETF has rallied 26 percent in 2019, tracking for its best quarter ever, while the market-cap weighted IBB ETF has gained 18 percent. David Nadig, managing director of ETF.com, said if an investor wants exposure to biotech, one of those ETFs stands above the other. "If you're playing biotech, you're...